Overexpression of EFNA2 in prostate cancer cells could accelerate cell migration and invasion in vitro and facilitate tumor metastasis and angiogenesis in xenograft mouse models while silencing of this gene reversed the above effects [47]. The gene discussed is EFNA2; the disease is neoplasm.